Evidence map›Paper›PMID 41231809›Full record

ArticlePloS one2025

Red cell distribution width and associated factors among hypertensive patients attending Arba Minch General Hospital, Southern Ethiopia: A comparative cross-sectional study.

Orgeta Robsha, Selamu Girma, Teklu Teshome, Tesfaye Kanko

Abstract readComparative Study
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Orgeta RobshaDepartment of Biomedical Sciences, School of Medicine, College of Medicine and Health Sciences, Dilla University, Dilla, Ethiopia.ORCID https://orcid.org/0009-0008-7625-648X
Selamu GirmaDepartment of Biomedical Sciences, School of Medicine, College of Medicine and Health Sciences, Dilla University, Dilla, Ethiopia.
Teklu TeshomeDepartment of Biomedical Sciences, School of Medicine, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.
Tesfaye KankoDepartment of Biomedical Sciences, School of Medicine, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRed cell distribution width (RDW) has been increasingly linked with cardiovascular and metabolic conditions. However, its clinical relevance in hypertension remains underexplored in Ethiopia. This study aimed to assess RDW levels, associated factors, and its potential utility in hypertension management.

methodsAn institution-based comparative cross-sectional study was conducted from November 2023 to January 2024 among 70 hypertensive patients and 70 age- and sex-matched normotensive controls. Hypertensive participants were consecutively recruited from the hypertension outpatient clinic, while controls were recruited from the general outpatient department using systematic random sampling. Data were collected using a pretested and structured interviewer-administered questionnaire via the KOBO Collect to obtain sociodemographic, lifestyle, and clinical information. Five milliliters of venous blood were drawn from each participant for hematological and biochemical analyses. Data were entered and analyzed using SPSS version 26.0. Independent t-test and Mann-Whitney U-test were used for group comparisons, multivariable logistic regression assessed associations, and Spearman correlation tested RDW versus hypertension duration. Receiver operating characteristic (ROC) curve analysis was performed to determine the predictive ability of RDW for detecting disease severity. A p-value < 0.05 was considered statistically significant.

resultsHypertensive patients had significantly higher mean RDW values compared to normotensive controls (15.1 ± 2.0% vs. 13.0 ± 2.0%, p < 0.001). RDW was higher in hypertensive patients with stage II (16.35 ± 2.60%) and poorly controlled blood pressure (16.00 ± 2.10%) compared to stage I (14.95 ± 2.10%) and controlled blood pressure (14.70 ± 1.20%). RDW showed a positive but non-significant correlation with hypertension duration (rs = 0.127, P = 0.295) and demonstrated a predictive power of 74.1% for detecting hypertension severity at a cut-off value of 14.5%. RDW was significantly elevated among participants who consumed alcohol (AOR = 6.48; 95% CI: 1.92-21.85), chewed khat (AOR = 5.65; 95% CI: 1.06-29.9), or had elevated C-reactive protein (AOR = 5.90; 95% CI: 1.67-20.89) and serum creatinine (AOR = 4.35; 95% CI: 1.19-15.91).

conclusionsA higher RDW reported among hypertensive patients compared to their counterparts, with RDW increasing across hypertension stages. These findings suggest a possible role of RDW as an indicator of hypertension progression. Therefore, assessing RDW may provide supportive information for the early identification and management of hypertension-related complications.

Indexed as

Erythrocyte IndicesHypertensionAdultAgedCase-Control StudiesCross-Sectional StudiesEthiopiaFemaleHospitals, GeneralHumansMaleMiddle AgedROC Curve

Identifiers

PMID41231809
PMCPMC12614529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.